Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity (Q35738935)

10 August 2017

title

Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity (English)

1 reference

10 August 2017

0 references

0 references

0 references

0 references

Christie M. Ballantyne

6

object named as

Christie M Ballantyne

1 reference

10 August 2017

Qun Wang

1

1 reference

10 August 2017

Xiaoyuan D Perrard

2

1 reference

10 August 2017

Jerry L Perrard

3

1 reference

10 August 2017

Amir Mansoori

4

1 reference

10 August 2017

C Wayne Smith

5

1 reference

10 August 2017

Huaizhu Wu

7

1 reference

10 August 2017

publication date

30 September 2010

1 reference

10 August 2017

1 reference

10 August 2017

volume

19

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

505-513

1 reference

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

CD11c expression in adipose tissue and blood and its role in diet-induced obesity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Endocannabinoid system in food intake and metabolic regulation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Cannabinoid type 1 receptor: another arrow in the adipocytes' bow.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Cannabinoids for the treatment of inflammation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Mechanisms linking obesity with cardiovascular disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Inflammation and metabolic disorders

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Obesity is associated with macrophage accumulation in adipose tissue

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The expression of adipogenic genes is decreased in obesity and diabetes mellitus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

12 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

CB1 antagonists for obesity--what lessons have we learned from rimonabant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Metabolic responses to long-term pharmacological inhibition of CB1-receptor activity in mice in relation to dietary fat composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272877

T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity

25 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.213

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2010.213

1 reference

10 August 2017

1 reference

10 August 2017

1 reference